← FDA Drug Approvals (Drugs@FDA)

EPTIFIBATIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS INC · Approved 2018-03-07

Drug application

FDA Application #

ANDA204693

Application type

Abbreviated New Drug Application (Generic)

Brand name

EPTIFIBATIDE

Generic name

EPTIFIBATIDE

Active ingredients

EPTIFIBATIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

SAGENT PHARMS INC

Manufacturer

Sagent Pharmaceuticals

First approval

2018-03-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown